Becton, Dickinson and Company: o společnosti
Becton, Dickinson and Company (BDX) je společnost ze sektoru zdravotnictví (Medical Instruments & Supplies). Sídlí Franklin Lakes, USA. Zaměstnává přibližně 72 000 lidí. Tržní kapitalizace je 49,8 mld. $. Generálním ředitelem je Thomas E. Polen Jr..
Základní údaje
- Sektor
- Zdravotnictví
- Odvětví
- Medical Instruments & Supplies
- Země
- USA
- Sídlo
- Franklin Lakes
- Zaměstnanci
- 72 000
- Generální ředitel
- Thomas E. Polen Jr.
- Web
- bd.com
- Tržní kapitalizace
- 49,8 mld. $
Popis podnikání
Popis společnosti v originále (anglicky), zdroj Yahoo Finance.
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Často kladené otázky
Čím se zabývá Becton, Dickinson and Company?
Becton, Dickinson and Company působí v sektoru zdravotnictví, v odvětví Medical Instruments & Supplies. Podrobný popis podnikání v angličtině najdete na této stránce.
Kde sídlí Becton, Dickinson and Company a kolik má zaměstnanců?
Sídlí Franklin Lakes, USA. Má přibližně 72 000 zaměstnanců.
Kdo je generálním ředitelem Becton, Dickinson and Company?
Generálním ředitelem je Thomas E. Polen Jr..
Data: Yahoo Finance, zpožděná a orientační. Výsledky z minulosti nezaručují budoucí výnos. Informace nejsou investičním doporučením.
Doporučení partneři